HRTX

Heron Therapeutics (HRTX)

About Heron Therapeutics (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Details

Daily high

$1.57

Daily low

$1.40

Price at open

52 Week High

$2.68

52 Week Low

$1.00

Market cap

273.2M

Dividend yield

0.00%

Volume

2,430

Avg. volume

2.1M

P/E ratio

-18.42

Heron Therapeutics News